# Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation

Study · id `cardio:ct-nct02996435` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02996435](<https://clinicaltrials.gov/study/NCT02996435>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02996435

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 139 participants.

## Technical summary

Registry record NCT02996435. Randomized; no masking; primary purpose other. Start 2016-12-21 (actual); primary completion 2018-03-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 139 participants (enrolled count; ClinicalTrials.gov record NCT02996435, source copy `cardio:ctgov-nct02996435-2018-10-26`, retrieved 2026-10-26)
- Started: 2016-12-21 (actual) (ClinicalTrials.gov record NCT02996435, source copy `cardio:ctgov-nct02996435-2018-10-26`, retrieved 2026-10-26)
- Primary completion: 2018-03-22 (actual) (ClinicalTrials.gov record NCT02996435, source copy `cardio:ctgov-nct02996435-2018-10-26`, retrieved 2026-10-26)
- Completion: 2018-03-22 (actual) (ClinicalTrials.gov record NCT02996435, source copy `cardio:ctgov-nct02996435-2018-10-26`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02996435, source copy `cardio:ctgov-nct02996435-2018-10-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02996435-2018-10-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
- Condition: Atrial Fibrillation
- Intervention (Behavioral): Mobile Application Intervention
- Intervention (Other): No Intervention
- Lead sponsor: Janssen Scientific Affairs, LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Janssen Scientific Affairs, LLC (`cardio:org-janssen-scientific-affairs-llc`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy of a centralized, blended electronic, and human intervention to improve direct oral anticoagulant adherence: Smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation (SmartADHERE) a randomized clinical trial (`cardio:pubmed-33676886`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 66cb6064d1f08ddceba7b3c412130b35883e95fca606f1c066d1c3617ba56fa0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
